900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Mental disorder caused by drug (disorder)	Preferred (foundation metadata concept)
Mental disorders during pregnancy, childbirth and the puerperium	Preferred (foundation metadata concept)
Mental disorders during pregnancy, childbirth and the puerperium (disorder)	Preferred (foundation metadata concept)
Mental health disorder	Acceptable (foundation metadata concept)
Mental health problem	Preferred (foundation metadata concept)
Mental health problem (finding)	Preferred (foundation metadata concept)
Mental illness	Acceptable (foundation metadata concept)
Mental state	Preferred (foundation metadata concept)
Mental state (observable entity)	Preferred (foundation metadata concept)
Mental state, behavior / psychosocial function observable	Preferred (foundation metadata concept)
Mental state, behavior / psychosocial function observable (observable entity)	Preferred (foundation metadata concept)
Mental status, drowsy	Acceptable (foundation metadata concept)
Mental status, unconsciousness	Acceptable (foundation metadata concept)
Mentally vague	Preferred (foundation metadata concept)
Mentally vague (finding)	Preferred (foundation metadata concept)
Meralgia paresthetica	Preferred (foundation metadata concept)
Meralgia paresthetica (disorder)	Preferred (foundation metadata concept)
Mercapto mix	Preferred (foundation metadata concept)
Mercapto mix (substance)	Preferred (foundation metadata concept)
Mercaptopurine	Preferred (foundation metadata concept)
Mercaptopurine (substance)	Preferred (foundation metadata concept)
Mercaptopurine 50 mg oral tablet	Preferred (foundation metadata concept)
Mercaptopurine only product	Preferred (foundation metadata concept)
Mercury	Preferred (foundation metadata concept)
Mercury (substance)	Preferred (foundation metadata concept)
Mercury and/or mercury compound	Preferred (foundation metadata concept)
Mercury and/or mercury compound (substance)	Preferred (foundation metadata concept)
Mercury compound	Preferred (foundation metadata concept)
Mercury compound (substance)	Preferred (foundation metadata concept)
Meridional amblyopia	Acceptable (foundation metadata concept)
Merkel cell carcinoma	Preferred (foundation metadata concept)
Merkel cell carcinoma	Preferred (foundation metadata concept)
Merkel cell carcinoma (disorder)	Preferred (foundation metadata concept)
Merkel cell carcinoma (morphologic abnormality)	Preferred (foundation metadata concept)
Merkel cell tumor	Acceptable (foundation metadata concept)
Merkel cell tumor	Acceptable (foundation metadata concept)
Meropenem	Preferred (foundation metadata concept)
Meropenem (substance)	Preferred (foundation metadata concept)
Meropenem 1 g and vaborbactam 1 g powder for solution for injection vial	Preferred (foundation metadata concept)
Meropenem 1 g powder for solution for injection vial	Preferred (foundation metadata concept)
Meropenem 500 mg powder for solution for injection vial	Preferred (foundation metadata concept)
Meropenem and vaborbactam only product	Preferred (foundation metadata concept)
Meropenem only product	Preferred (foundation metadata concept)
Merozoite of Plasmodium falciparum	Acceptable (foundation metadata concept)
Merozoite of Plasmodium falciparum (organism)	Preferred (foundation metadata concept)
Merozoite of Plasmodium malariae	Acceptable (foundation metadata concept)
Merozoite of Plasmodium malariae (organism)	Preferred (foundation metadata concept)
Merozoite of Plasmodium ovale	Acceptable (foundation metadata concept)
Merozoite of Plasmodium ovale (organism)	Preferred (foundation metadata concept)
Merozoite of Plasmodium vivax	Acceptable (foundation metadata concept)
Merozoite of Plasmodium vivax (organism)	Preferred (foundation metadata concept)
Merozoite of genus Plasmodium	Acceptable (foundation metadata concept)
Merozoite of genus Plasmodium (organism)	Preferred (foundation metadata concept)
Merthiolate	Acceptable (foundation metadata concept)
Mesalamine	Preferred (foundation metadata concept)
Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet	Preferred (foundation metadata concept)
Mesalamine 1 g gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine 1 g rectal suppository	Preferred (foundation metadata concept)
Mesalamine 1.2 g gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine 2 g gastro-resistant and prolonged-release oral granules sachet	Preferred (foundation metadata concept)
Mesalamine 250 mg gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine 250 mg rectal suppository	Preferred (foundation metadata concept)
Mesalamine 4 g gastro-resistant and prolonged-release oral granules sachet	Preferred (foundation metadata concept)
Mesalamine 400 mg gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine 500 mg gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine 500 mg rectal suppository	Preferred (foundation metadata concept)
Mesalamine 66.7 mg/mL rectal suspension	Preferred (foundation metadata concept)
Mesalamine 800 mg gastro-resistant and prolonged-release oral tablet	Preferred (foundation metadata concept)
Mesalamine only product	Preferred (foundation metadata concept)
Mesalazine	Acceptable (foundation metadata concept)
Mesalazine (substance)	Preferred (foundation metadata concept)
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet	Acceptable (foundation metadata concept)
Mesalazine 1 g gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine 1 g rectal suppository	Acceptable (foundation metadata concept)
Mesalazine 1.2 g gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet	Acceptable (foundation metadata concept)
Mesalazine 250 mg gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine 250 mg rectal suppository	Acceptable (foundation metadata concept)
Mesalazine 4 g gastro-resistant and prolonged-release oral granules sachet	Acceptable (foundation metadata concept)
Mesalazine 400 mg gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine 500 mg gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine 500 mg rectal suppository	Acceptable (foundation metadata concept)
Mesalazine 66.7 mg/mL rectal suspension	Acceptable (foundation metadata concept)
Mesalazine 800 mg gastro-resistant and prolonged-release oral tablet	Acceptable (foundation metadata concept)
Mesalazine only product	Acceptable (foundation metadata concept)
Mesangiocapillary glomerulonephritis	Preferred (foundation metadata concept)
Mesangiocapillary glomerulonephritis (disorder)	Preferred (foundation metadata concept)
Mesangium	Acceptable (foundation metadata concept)
Mesenteric lymph node	Acceptable (foundation metadata concept)
Mesenteric lymphadenitis	Preferred (foundation metadata concept)
Mesenteric lymphadenitis (disorder)	Preferred (foundation metadata concept)
Mesenteric vein	Acceptable (foundation metadata concept)
Mesentery	Acceptable (foundation metadata concept)
Mesentery structure	Preferred (foundation metadata concept)
Mesentery structure (body structure)	Preferred (foundation metadata concept)
Mesna	Preferred (foundation metadata concept)
Mesna (substance)	Preferred (foundation metadata concept)
Mesna 100 mg/mL solution for injection	Preferred (foundation metadata concept)
Mesna 400 mg oral tablet	Preferred (foundation metadata concept)
Mesna 600 mg oral tablet	Preferred (foundation metadata concept)
Mesna only product	Preferred (foundation metadata concept)

Start Previous Page 312 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)